Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
41.75
+1.75 (4.38%)
Mar 16, 2026, 4:00 PM EDT - Market closed
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $2.07 billion as of March 17, 2026. Its market cap has increased by 518.20% in one year.
Market Cap
2.07B
Enterprise Value
1.59B
1-Year Change
518.20%
Ranking
Category
Stock Price
$41.75
Market Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $2.07B, an increase of 143.54%. That is a compound annual growth rate of 78.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.98B | 35.06% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 2.17B |
| Galapagos NV | 2.16B |
| Mineralys Therapeutics | 2.15B |
| Syndax Pharmaceuticals | 2.12B |
| Ultragenyx Pharmaceutical | 2.12B |
| Zai Lab | 2.11B |
| Nektar Therapeutics | 2.09B |
| Adaptive Biotechnologies | 2.06B |